Penumbra, Inc. (NYSE: PEN)
Health Care · Health Care Equipment & Supplies · US
$320.27
+0.27% today · +22.2% 1Y
Penumbra, Inc. (NYSE: PEN) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $12.58B and employs 4,700 people.
Over the last twelve months the share price has gained 22.2%, trading between 221.26 and 362.41.
Tweenvest scores Penumbra, Inc. across four factors: quality 79/100, value 52/100, growth 83/100. Its strongest factor is growth.
PEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.58B
- Revenue (TTM)
- $1.50B
- P/E
- 78.52
- EPS
- 4.07
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- $362.41
- 52-week low
- $221.26
- Avg volume (3M)
- —
- Shares outstanding
- 39.39M
- Employees
- 4,700
- Next earnings
- —
About Penumbra, Inc.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
- ISIN
- US70975L1070
- Founded
- 2004
- Listed since
- Sep 18, 2015
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Coloplast A/SCPSE: COLO B | $14.70B | Dkr446.30 | +2.39% |
| Olympus CorporationTSE: 7733 | $13.42B | ¥2,000.00 | +0.50% |
| Shanghai United Imaging Healthcare Co., Ltd.SHSE: 688271 | $13.15B | CN¥107.78 | +0.38% |
| Baxter International Inc.NYSE: BAX | $12.59B | $24.61 | +1.05% |
| Smith & Nephew plcLSE: SN. | $11.36B | £10.21 | +1.69% |
| bioMérieux S.A.ENXTPA: BIM | $10.96B | €84.05 | +1.02% |
| Demant A/SCPSE: DEMANT | $10.78B | Dkr350.80 | +2.81% |
| The Cooper Companies, Inc.NasdaqGS: COO | $10.34B | $55.45 | +1.99% |
Figures last refreshed Oct 11, 2026.